The store will not work correctly when cookies are disabled.
7-Ethyl-4-(2-methoxypyridin-4-yl)-7H-imidazo[4,5-c]pyridazine
ID: ALA4514448
PubChem CID: 155539210
Max Phase: Preclinical
Molecular Formula: C13H13N5O
Molecular Weight: 255.28
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CCn1cnc2c(-c3ccnc(OC)c3)cnnc21
Standard InChI: InChI=1S/C13H13N5O/c1-3-18-8-15-12-10(7-16-17-13(12)18)9-4-5-14-11(6-9)19-2/h4-8H,3H2,1-2H3
Standard InChI Key: ZZZUWNYLFYIHHT-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
12.9333 -24.9862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9322 -25.8057 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.6402 -26.2147 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.6384 -24.5773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3470 -24.9826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3519 -25.8058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1363 -26.0556 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.6163 -25.3868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1284 -24.7237 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.6332 -23.7630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3413 -23.3529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3392 -22.5365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6297 -22.1292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9209 -22.5443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9265 -23.3593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3933 -26.8313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8500 -27.4418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2106 -22.1403 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.2052 -21.3231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
4 10 1 0
7 16 1 0
16 17 1 0
14 18 1 0
18 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 255.28 | Molecular Weight (Monoisotopic): 255.1120 | AlogP: 1.92 | #Rotatable Bonds: 3 |
Polar Surface Area: 65.72 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.59 | CX LogP: 0.88 | CX LogD: 0.88 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.71 | Np Likeness Score: -1.46 |
References
1. Owen RM, Blakemore D, Cao L, Flanagan N, Fish R, Gibson KR, Gurrell R, Huh CW, Kammonen J, Mortimer-Cassen E, Nickolls SA, Omoto K, Owen D, Pike A, Pryde DC, Reynolds DS, Roeloffs R, Rose C, Stead C, Takeuchi M, Warmus JS, Watson C.. (2019) Design and Identification of a Novel, Functionally Subtype Selective GABAA Positive Allosteric Modulator (PF-06372865)., 62 (12): [PMID:30964988] [10.1021/acs.jmedchem.9b00322] |